Regulatory Submissions, Information, and Document Management Forum

In a world that has faced significant scientific, regulatory, and ethical challenges due to the global pandemic, this session will discuss the future of drug development, where the life sciences R&D industry is headed, and why. The keynote will shine a spotlight on the rapid changes in science and technology, such as the convergence of biology and machine learning, along with the increasing importance of real-world data for evidence generation. This session will also emphasize the importance of the need for regulatory sciences and policy to adapt to these changes, the significance of ethical discussions and how they impact our decision making for R&D and highlight the learnings from the pandemic and how to implement these learnings into your own organization.